Please login to the form below
Alison Cantle
This page shows the latest Alison Cantle news and features for those working in and with pharma, biotech and healthcare.
Lucid launches rare and specialist disease agency
Vivid MedComms will be headed by Alison Cantle. UK-based Lucid Group, has opened Vivid Medcomms, a new agency that will focus on rare diseases and be based in Buckinghamshire, UK. ... Vivid will be headed up by managing director Alison Cantle, who was
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Bedrock Group bolsters team with three key appointments
We are delighted to have Andy on board,” says Alison Cantle, managing director.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Bedrock Group strengthens its senior team
We are delighted to have Derek, Christine and Andrea join us at this exciting time for Bedrock, as we continue our growth throughout 2020” says Alison Cantle, Managing Director.
-
Bedrock double up
Alison Cantle, Managing Director at Bedrock Health said “I am so proud of our fantastic team at Bedrock.
-
Bedrock strengthens its senior team
We are delighted to have Catherine as part of our senior management team” says Alison Cantle, Managing Director.
-
Bedrock Group celebrates a trio of new hires
We are delighted to have Andy on board,” says Alison Cantle, Managing Director.
-
Bedrock’s on fire for Wellbeing Week
To complete the focus on wellbeing, there is nothing quite like a nice cup of tea and something sweet, so Alison Cantle, Bedrock Managing Director, baked a cake for the team,
More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
